MMI News

Congratulations to Dr. Fikadu Tafesse and the Tafesse Lab on the American Lung Association Innovation Award for your project titled: “Defining the roles of diacylglycerol in Mtb infection using multi-functional chemical probes.”

We have some exciting news from the Johnson Lab related to COVID-19 testing. They are collaborating with a lab at VGTI and Donna Hansel in the COVID testing laboratory to get testing of COVID antibodies going across the state of Oregon.

Congratulations to Dr. Bella Rauch and the Rauch Lab! They just received an award for their project "Mechanisms of inflammasome induced epithelial cell extrusion" from the Collins Medical Trust.

Congratulations to Dr. Bahareh Ajami and the Ajami Lab! They just received a new grant award for their project, entitled, "Advanced Single Cell Proteogenomic Approaches to Studying microglial heterogeneity in Alzheimer’s Disease" from the Collins Medical Trust. 

Congratulations to Dr. Jeff Nolz and the Nolz lab! They just received an R01 Supplement for COVID-19 Research from NIAID for their project entitled “Immunogenicity of Vaccinia virus vectors expressing modified versions of the SARS-CoV-2 Spike protein as a vaccine candidate”.

Congratulations to Dr. Fikadu Tafesse and the Tafesse Lab! Their project, titled, SARS-CoV-2 Nanobodies as Therapeutics Against COVID-19, was just funded by the Biomedical Innovation Program (BIP) COVID-19 Rapid Response.

Congratulations to the Lind Lab on their new publication entitled “Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.” It was accepted in The Proceedings of the National Academy of Sciences (PNAS).

Congratulations to Dr. Eric Barklis on getting a new MRF grant entitled “Analysis of HIV-1 Gag-Envelope Protein Interactions.”

Congratulations to Dr. Fikadu Tafesse on receiving a new R01 grant entitled “Determining the role of sphingolipids in Mycobacterium tuberculosis infection.”

We are very proud to announce that two MMI Professors, Scott Landfear and Mike Riscoe, have been elected to the American Academy of Microbiology - the honorific society of the American Society for Microbiology.  This is a richly deserved honor and celebrates Dr. Landfear’s work in the field of molecular parasitology, which he helped pioneer in the early 1980s. The award also recognizes Dr. Landfear’s extensive work on nutrient uptake pathways in Leishmania (as well as trypanosomes and Plasmodium), with particular emphasis on glucose and purines.   This prestigious honor recognizes Dr. Riscoe’spioneering work with an innovative high-throughput screening approach to discover novel antimalarial drugs. The accolade also recognizes Professor Riscoe’s current work to establish the use of a compound not only as an antimalarial drug but also as a prophylactic therapeutic, which highlights the importance of his research for public health.

Congratulations to Dr. Bill Messer and the Messer Lab on receiving a new R01 grant entitled "Long term immunity following yellow fever vaccination.”

Congratulations to Iris Jones, awarded the NIH Individual Fellowship – F31 Grant!

Congratulations to Sam Hobbs for receiving a fundable score on his F31 NRSA Fellowship.

Congratulations to Jeff Nolz, Ph.D., on his promotion to associate professor! This career milestone is a testament to his accomplishments and to his trajectory in investigating the mechanisms of T cell trafficking, activation, function and differentiation.

Welcoming new faculty: Please join us in welcoming Bahareh Ajami, Ph.D., as an assistant professor, to the Department of Molecular Microbiology and Immunology and the Department of Behavioral Neuroscience. Dr. Ajami’s research is focused on advancing our understanding of the function and biology of the brain’s intrinsic immune cells: microglia. 

Dr. Ajami's previous work has established the fate and origin of microglia in the brain during health and disease. In her most recent work, by adopting a novel single-cell proteomics approach, CyTOF (mass cytometry), Dr. Ajami has demonstrated that microglia are a network of cells comprised of several subpopulations with distinct immune responses in different neurological disorders. This work has resulted in the discovery of a new therapeutic target for Multiple Sclerosis and ALS disease and has recently been licensed by a biotech company for further development. 

Drawing on her recent discovery of different microglia subsets combined with proteogenomics approaches and computational methods, Dr. Ajami’s research program will focus on understanding of microglia subset functional specialization and the mechanisms that control the functional identity of different subsets both in mice and humans. Her lab will examine how these regulations are changed in different neurodegenerative diseases such as ALD and AD, revealing their endowed capacity to induce distinct types of neurodegenerative diseases and designing novel strategies to target them for therapies.

Congratulations to Rosenzweig Lab! The lab has been awarded with NIH R01 funding, and Ruth Napier, Ph.D., has been awarded with the VA Career Development Award. 

Open position for an assistant professor: The Department of Molecular Microbiology and Immunology, in collaboration with the Department of Behavioral Neuroscience, invites applications at the assistant professor level to work on the basic or translational aspects of neuroimmunology. See Research Opportunities for details.

SOM News: Leadership team selected for new Ph.D. Program in Biomedical Sciences.

A new recruitment has been opened for the Dean’s Research Scholar Program.  Applications are due by November 25, 2018. Find details on the program and application requirements.

Congratulations to Ruth Napier, Ph.D., for getting awarded a Medical Research Foundation Grant for her project Investigation of NOD2 as a T cell intrinsic regulator of rheumatoid arthritis.

SOM News: Paths to Leadership and faculty development.

SOM News: Dr. Georgiana Purdy appointed to NIH Bacterial Pathogenesis Study Section.

Congratulations to Tafesse lab. They've received a grant from the Bill & Melinda Gates Foundation for their research project, Nanobodies as a Targeted-Therapeutic Against MtbRead more.

Congratulations to Nolz Lab and Hill Lab. Their recently published article, Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8(+) T cells, has been recommended in F1000Prime for having special significance in its field.